NEO
Neogenomics Inc
Price:  
14.21 
USD
Volume:  
931,681.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NEO WACC - Weighted Average Cost of Capital

The WACC of Neogenomics Inc (NEO) is 7.1%.

The Cost of Equity of Neogenomics Inc (NEO) is 8.00%.
The Cost of Debt of Neogenomics Inc (NEO) is 5.50%.

Range Selected
Cost of equity 6.10% - 9.90% 8.00%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.4% - 8.8% 7.1%
WACC

NEO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.49 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 9.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.3 0.3
Cost of debt 4.00% 7.00%
After-tax WACC 5.4% 8.8%
Selected WACC 7.1%